As featured in WSJ Pro, July 2026
In a recent WSJ Pro interview, Bob Zambon, Vice President, Product, Clinical Trials at ConcertAI, discusses why timing is one of the biggest barriers to clinical trial participation—and how applied AI through TriaLinQ is helping connect the right patients to the right trials at the right time.
Read the full article →